Understanding how Lewy bodies spread in Parkinson's and related conditions
Propagation of Lewy pathology in Parkinson's and related disorders
This research explores how abnormal protein clumps, called Lewy bodies, form and spread in the brain, contributing to conditions like Parkinson's and Alzheimer's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10994601 on NIH RePORTER |
What this research studies
Many brain disorders, including Parkinson's and Alzheimer's, involve the buildup of misshapen proteins. This project focuses on specific protein clumps called Lewy bodies, which are a key feature in Parkinson's disease and a related condition called Dementia with Lewy Bodies. We are learning how these Lewy bodies form and spread throughout the brain, similar to how infections might spread. Our work uses advanced tools to understand these processes, which could lead to new ways to slow or stop disease progression.
Who could benefit from this research
Good fit: This foundational research is for individuals interested in the underlying causes of Parkinson's disease, Lewy body dementia, and Alzheimer's disease, as it aims to understand disease mechanisms.
Not a fit: Patients seeking immediate new treatments or direct clinical intervention would not directly benefit from this basic science research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that prevent or slow the spread of harmful protein clumps in the brain, potentially delaying or reducing symptoms of Parkinson's, Lewy body dementia, and some forms of Alzheimer's.
How similar studies have performed: Early findings from this and other groups have shown that these protein clumps can indeed spread in laboratory models, suggesting this approach is promising.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Luk, Kelvin C — University of Pennsylvania
- Study coordinator: Luk, Kelvin C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.